NM_000535.7:c.353G>A
Variant summary
Our verdict is Pathogenic. The variant received 20 ACMG points: 20P and 0B. PS3PM2PM5PP3_StrongPP5_Very_Strong
The NM_000535.7(PMS2):c.353G>A(p.Ser118Asn) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000145 in 1,380,492 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV005625916: Assessment of experimental evidence suggests this variant results in abnormal RNA splicing, resulting in premature termination of the protein (PMID:31992580 (2020), 38311346 (2024)).; SCV002617279: RNA studies have demonstrated that this alteration results in abnormal splicing in the set of samples tested (Ambry internal data).". Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S118T) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000535.7 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Lynch syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- mismatch repair cancer syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Muir-Torre syndromeInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000535.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | MANE Select | c.353G>A | p.Ser118Asn | missense splice_region | Exon 4 of 15 | NP_000526.2 | P54278-1 | ||
| PMS2 | c.539G>A | p.Ser180Asn | missense splice_region | Exon 5 of 16 | NP_001393795.1 | A0A8V8TNX6 | |||
| PMS2 | c.353G>A | p.Ser118Asn | missense splice_region | Exon 4 of 15 | NP_001308943.1 | A0A8V8TQ50 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | TSL:1 MANE Select | c.353G>A | p.Ser118Asn | missense splice_region | Exon 4 of 15 | ENSP00000265849.7 | P54278-1 | ||
| PMS2 | TSL:1 | c.353G>A | p.Ser118Asn | missense splice_region | Exon 4 of 11 | ENSP00000371758.4 | P54278-2 | ||
| PMS2 | TSL:1 | n.353G>A | splice_region non_coding_transcript_exon | Exon 4 of 13 | ENSP00000514464.1 | P54278-3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000426 AC: 1AN: 234884 AF XY: 0.00000775 show subpopulations
GnomAD4 exome AF: 0.00000145 AC: 2AN: 1380492Hom.: 0 Cov.: 24 AF XY: 0.00000145 AC XY: 1AN XY: 691286 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at